Fajnkuchen F - Search Results

1

[Treatment of severe Behçet's disease with anti-TNF-alpha: infliximab. A case report].

Andreu M, Ramanoelina J, Fajnkuchen F, Mouthon L, Cohen P, Laroche L, Guillevin L. Andreu M, et al. Among authors: fajnkuchen f. Ann Med Interne (Paris). 2002 Oct;153(6):414-5. Ann Med Interne (Paris). 2002. PMID: 12486393 French. No abstract available.

2

A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS).

Stefanickova J, Cunha-Vaz J, Ulbig M, Pearce I, Fernández-Vega Sanz A, Theodossiadis P, Kodjikian L, Izmailov A, Muston D, Vassilev Z, Lamotte B, Tückmantel C, Friedl S, Altemark A, Schwarz HJ, Katz T; POLARIS study investigators. Stefanickova J, et al. Acta Ophthalmol. 2018 Dec;96(8):e942-e949. doi: 10.1111/aos.13771. Epub 2018 Apr 25. Acta Ophthalmol. 2018. PMID: 29696809 Free PMC article.

3

Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome.

Dossarps D, Bron AM, Koehrer P, Aho-Glélé LS, Creuzot-Garcher C; FRCR net (FRenCh Retina specialists net). Dossarps D, et al. Am J Ophthalmol. 2015 Jul;160(1):17-25.e1. doi: 10.1016/j.ajo.2015.04.013. Epub 2015 Apr 16. Am J Ophthalmol. 2015. PMID: 25892127

4

Results of one-year's treatment with ranibizumab for exudative age-related macular degeneration in a clinical setting.

Cohen SY, Dubois L, Tadayoni R, Fajnkuchen F, Nghiem-Buffet S, Delahaye-Mazza C, Guiberteau B, Quentel G. Cohen SY, et al. Among authors: fajnkuchen f. Am J Ophthalmol. 2009 Sep;148(3):409-13. doi: 10.1016/j.ajo.2009.04.001. Epub 2009 May 24. Am J Ophthalmol. 2009. PMID: 19477713

5

Review and comparison of methodologies for indirect comparison of clinical trial results: an illustration with ranibizumab and aflibercept.

Regnier SA, Alsop J, Wright J, Nixon R, Staines H, Fajnkuchen F. Regnier SA, et al. Among authors: fajnkuchen f. Expert Rev Pharmacoecon Outcomes Res. 2016 Dec;16(6):793-801. doi: 10.1586/14737167.2016.1165609. Epub 2016 Mar 25. Expert Rev Pharmacoecon Outcomes Res. 2016. PMID: 26967930

6

Outcomes after a 1-Year Treatment with Ranibizumab for Diabetic Macular Edema in a Clinical Setting.

Hrarat L, Fajnkuchen F, Boubaya M, Lévy V, Sarda V, Grenet T, Nghiem-Buffet S, Chaine G, Giocanti-Auregan A. Hrarat L, et al. Among authors: fajnkuchen f. Ophthalmologica. 2016;236(4):207-214. doi: 10.1159/000453006. Epub 2016 Nov 30. Ophthalmologica. 2016. PMID: 27898414

7

[Sudden visual loss].

Fajnkuchen F, Chaine G. Fajnkuchen F, et al. Rev Prat. 2002 Apr 1;52(7):771-9. Rev Prat. 2002. PMID: 12032965 French. No abstract available.

8

Central retinal vein occlusion in bird-shot retinochoroidopathy.

Fajnkuchen F, Giraud C, Gatinel D, Chaine G. Fajnkuchen F, et al. Arch Ophthalmol. 2002 Jul;120(7):987-9. Arch Ophthalmol. 2002. PMID: 12096977 No abstract available.

9

Takayasu disease revealed by bilateral loss of vision.

Rohart C, Abad S, Badelon I, Fajnkuchen F, Warzocha U, Dhôte R, Chaine G. Rohart C, et al. Among authors: fajnkuchen f. Retin Cases Brief Rep. 2009 Spring;3(2):174-6. doi: 10.1097/ICB.0b013e3181607a26. Retin Cases Brief Rep. 2009. PMID: 25391067

10

Functional and Anatomical Outcomes in Patients With Serous Retinal Detachment in Diabetic Macular Edema Treated With Ranibizumab.

Giocanti-Aurégan A, Hrarat L, Qu LM, Sarda V, Boubaya M, Levy V, Chaine G, Fajnkuchen F. Giocanti-Aurégan A, et al. Among authors: fajnkuchen f. Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):797-800. doi: 10.1167/iovs.16-20855. Invest Ophthalmol Vis Sci. 2017. PMID: 28152140

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters